Acta Neurologica Scandinavica · 1999 · 93 citations · 9 references
Life SciencesNutritional SciencesPharmacologyClinical NutritionHuman NutritionSleep MedicineBioactive Food ComponentsEssential Fatty AcidsFatigueFatty Acid MetabolismLipid MetabolismMedical Nutrition TherapyEicosapentaenoic AcidEssential Fatty Acid ProfileFatigue ReliefFatty AcidsOmega-6 Fatty AcidsPlacebo ComparatorsPlacebo Effect In TreatmentPlacebo-controlled Efficacy Assessment
OBJECTIVE: To replicate the treatment study by Behan et al. (1990) using current research criteria for Chronic Fatigue Syndrome (CFS). METHOD: Fifty patients who fulfilled the Oxford Criteria for CFS were randomly allocated to treatment with either Efamol Marine or placebo for 3 months. They were seen monthly and completed a physical symptoms checklist and the Beck Inventory for Depression and reported if they were the same, better or worse at the end of the study. RESULTS: Symptoms generally improved with time but not significantly and there were no significant differences between the treatment and placebo groups. Pretreatment red-cell membrane (RBC) lipids of patients compared with age-and sex-matched normal controls showed no significant differences. DISCUSSION: The results of this study contrast sharply with the previous study where 85% of patients had a clinically significant improvement of symptoms with Efamol Marine over a 3-month treatment period.
9
An Inventory for Measuring Depression
Aaron T. Beck · Archives of General Psychiatry · 1961 · 38.2K citations
Chronic Fatigue Syndrome: A Working Case Definition
Gary P. Holmes · Annals of Internal Medicine · 1988 · 1.7K citations
CHRONIC ENTEROVIRUS INFECTION IN PATIENTS WITH POSTVIRAL FATIGUE SYNDROME
G.E. Yousef, G.F. Mann, David G. Smith et al. · The Lancet · 1988 · 341 citations